nach oben

Erschienen in:

01.08.2020 | Clinical study

Inflammatory bowel disease with isotretinoin in acne vulgaris

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

The incidence of inflammatory bowel disease (IBD) in patients receiving isotretinoin for acne vulgaris (AV) appears to be very low, according to study results reported in the Journal of the American Academy of Dermatology, and "the risk appears similar to unexposed patients with AV". …

1. Wright S, et al. Risk of new onset inflammatory bowel disease among acne vulgaris patients exposed to isotretinoin. Journal of the American Academy of Dermatology : 16 Jul 2020. Available from: URL: http://doi.org/10.1016/j.jaad.2020.07.042

2. Barbieri JS. Isotretinoin and risk of inflammatory bowel disease: more data to support lack of meaningful risk. Journal of the American Academy of Dermatology : 16 Jul 2020. Available from: URL: http://doi.org/10.1016/j.jaad.2020.07.041

Titel: Inflammatory bowel disease with isotretinoin in acne vulgaris
Publikationsdatum: 01.08.2020
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-020-81333-9

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Inflammatory bowel disease with isotretinoin in acne vulgaris

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2020

Anlotinib

Eribulin/pegfilgrastim

Multiple drugs

Gabapentin

Bisoprolol/fentanyl/midazolam

Adverse drug reactions and causality assessment in neonates